• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Methicillin-resistant Staphylococcus epidermidis in infection of hip arthroplasties.

作者信息

James P J, Butcher I A, Gardner E R, Hamblen D L

机构信息

Western Infirmary, Glasgow, Scotland, UK.

出版信息

J Bone Joint Surg Br. 1994 Sep;76(5):725-7.

PMID:8083259
Abstract

We investigated the incidence of cephalosporin-resistant bacteria in infected hip arthroplasties. Of 740 patients having hip replacement or related procedures performed over three years, 30 had positive bacteriological cultures from tissue removed at the time of surgery. In 18 of the 30 cultures Staphylococcus epidermidis was grown and 12 of these were methicillin-resistant. A prospective study of skin swabs taken from 100 consecutive patients at the time of admission for THR showed methicillin-resistant Staphylococcus epidermidis in 25. This cephalosporin-resistant organism was shown to be the commonest proven cause of infection, and its presence as a skin commensal raises important questions about current antibiotic prophylaxis for joint replacement.

摘要

相似文献

1
Methicillin-resistant Staphylococcus epidermidis in infection of hip arthroplasties.
J Bone Joint Surg Br. 1994 Sep;76(5):725-7.
2
Two-stage treatment of chronic staphylococcal orthopaedic implant-related infections using vancomycin impregnated PMMA spacer and rifampin containing antibiotic protocol.使用万古霉素浸渍的聚甲基丙烯酸甲酯(PMMA)间隔物和含利福平的抗生素方案对慢性金黄色葡萄球菌骨科植入物相关感染进行两阶段治疗。
Bull Hosp Jt Dis. 1999;58(2):79-85.
3
Successful treatment of methicillin-resistant Staphylococcus epidermidis prosthetic joint infection with telavancin.用替考拉宁成功治疗耐甲氧西林表皮葡萄球菌人工关节感染。
J Antimicrob Chemother. 2012 Aug;67(8):2052-3. doi: 10.1093/jac/dks165. Epub 2012 Apr 27.
4
Periprosthetic joint infection: the economic impact of methicillin-resistant infections.人工关节感染:耐甲氧西林感染的经济影响。
J Arthroplasty. 2010 Sep;25(6 Suppl):103-7. doi: 10.1016/j.arth.2010.04.011. Epub 2010 May 31.
5
[Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].利奈唑胺治疗肌肉骨骼系统耐抗生素革兰氏阳性菌感染
Acta Chir Orthop Traumatol Cech. 2006 Oct;73(5):329-33.
6
Results of periprosthetic hip and knee infections caused by resistant bacteria.耐抗生素细菌所致人工髋关节和膝关节周围感染的结果
Clin Orthop Relat Res. 2002 Nov(404):116-24. doi: 10.1097/00003086-200211000-00021.
7
[Prolonged treatment with dalbavancin in prosthetic hip infection by methicillin-resistant Staphylococcus epidermidis].[达巴万星对耐甲氧西林表皮葡萄球菌所致人工髋关节感染的长期治疗作用]
Rev Esp Quimioter. 2019 Apr;32(2):203-204. Epub 2019 Mar 13.
8
Guiding empirical antibiotic therapy in orthopaedics: The microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention.指导骨科经验性抗生素治疗:清创、冲洗和保留假体治疗的人工关节感染的微生物学
J Infect. 2007 Jul;55(1):1-7. doi: 10.1016/j.jinf.2007.01.007. Epub 2007 Mar 6.
9
Continuous high-dose vancomycin combination therapy for methicillin-resistant staphylococcal prosthetic hip infection: a prospective cohort study.连续高剂量万古霉素联合治疗耐甲氧西林金黄色葡萄球菌人工髋关节感染:一项前瞻性队列研究。
Clin Microbiol Infect. 2013 Feb;19(2):E98-105. doi: 10.1111/1469-0691.12071. Epub 2012 Dec 10.
10
Linezolid treatment of prosthetic hip Infections due to methicillin-resistant Staphylococcus aureus (MRSA).利奈唑胺治疗耐甲氧西林金黄色葡萄球菌(MRSA)所致人工髋关节感染
J Infect. 2001 Aug;43(2):148-9. doi: 10.1053/jinf.2001.0863.

引用本文的文献

1
Detection of the mecA Gene and Its Association With Antimicrobial Resistance Among Coagulase-Negative Staphylococci Isolated From Clinical Samples in a Tertiary Care Hospital: A Cross-Sectional Study.三级护理医院临床样本分离的凝固酶阴性葡萄球菌中mecA基因的检测及其与抗菌药物耐药性的关系:一项横断面研究
Cureus. 2025 Apr 3;17(4):e81643. doi: 10.7759/cureus.81643. eCollection 2025 Apr.
2
Genomics of Staphylococcus aureus and Staphylococcus epidermidis from Periprosthetic Joint Infections and Correlation to Clinical Outcome.假体周围关节感染的金黄色葡萄球菌和表皮葡萄球菌的基因组学及其与临床结果的相关性。
Microbiol Spectr. 2022 Aug 31;10(4):e0218121. doi: 10.1128/spectrum.02181-21. Epub 2022 Jun 28.
3
Methicillin-Resistant Lineages in the Nasal and Skin Microbiota of Patients Planned for Arthroplasty Surgery.
计划进行关节置换手术患者鼻腔和皮肤微生物群中的耐甲氧西林谱系
Microorganisms. 2021 Jan 28;9(2):265. doi: 10.3390/microorganisms9020265.
4
Distribution characteristics of spp. in different phases of periprosthetic joint infection: A review.假体周围关节感染不同阶段的物种分布特征:综述
Exp Ther Med. 2017 Jun;13(6):2599-2608. doi: 10.3892/etm.2017.4300. Epub 2017 Apr 4.
5
Prevalence and molecular characterization of methicillin resistance among Coagulase-negative Staphylococci at a tertiary care center.某三级医疗中心凝固酶阴性葡萄球菌中甲氧西林耐药性的患病率及分子特征
Med J Armed Forces India. 2016 Dec;72(Suppl 1):S54-S58. doi: 10.1016/j.mjafi.2016.03.007. Epub 2016 Jun 24.
6
The use of BMP-2 coupled - Nanosilver-PLGA composite grafts to induce bone repair in grossly infected segmental defects.使用 BMP-2 偶联 - Nanosilver-PLGA 复合移植物诱导严重感染的节段性缺损骨修复。
Biomaterials. 2010 Dec;31(35):9293-300. doi: 10.1016/j.biomaterials.2010.08.041. Epub 2010 Sep 22.
7
[The treatment of periprosthetic infections].
Z Rheumatol. 2007 Feb;66(1):28-33. doi: 10.1007/s00393-006-0141-5.
8
Teicoplanin-containing cement spacers for treatment of experimental Staphylococcus aureus joint prosthesis infection.含替考拉宁的骨水泥间隔物用于治疗实验性金黄色葡萄球菌人工关节感染
Antimicrob Agents Chemother. 2003 Oct;47(10):3365-7. doi: 10.1128/AAC.47.10.3365-3367.2003.
9
Combination of quinupristin-dalfopristin (Synercid) and rifampin is highly synergistic in experimental Staphylococcus aureus joint prosthesis infection.奎奴普丁-达福普汀(Synercid)与利福平联合使用,在实验性金黄色葡萄球菌人工关节感染中具有高度协同作用。
Antimicrob Agents Chemother. 2002 Apr;46(4):1122-4. doi: 10.1128/AAC.46.4.1122-1124.2002.
10
Phenotypic and genomic variation among Staphylococcus epidermidis strains infecting joint prostheses.感染关节假体的表皮葡萄球菌菌株之间的表型和基因组变异。
J Clin Microbiol. 1999 May;37(5):1306-12. doi: 10.1128/JCM.37.5.1306-1312.1999.